Hochschulschrift
The angiogenic factors placental growth factor (PIGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) can be used for predicting preeclampsia and intrauterine growth restriction as well as classifying preeclampsia according to severity : = Die Angiogenesefaktoren Placental growth factor (PIGF) und soluble FMS-like tyrosine Kinase 1 (sFlt-1) könnten sowohl zur Prädiktion der Präeklampsie und der intrauterinen Wachstumsrestriktion, als auch für die Klassifikation des Schweregrades verwendet werden
- Alternative title
-
Die Angiogenesefaktoren Placental growth factor (PIGF) und soluble FMS-like tyrosine Kinase 1 (sFlt-1) könnten sowohl zur Prädiktion der Präeklampsie und der intrauterinen Wachstumsrestriktion, als auch für die Klassifikation des Schweregrades verwendet werden
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
110 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Johannes Gutenberg-Universität Mainz, Dissertation, 2015
- Classification
-
Medizin, Gesundheit
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:21 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria
Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
Die Wertigkeit von placental growth factor (PlGF) und soluble fms-like tyrosine kinase-1 (sFlt-1) im Rahmen des Erst-Trimester-Screenings.
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria
Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
Die Wertigkeit von placental growth factor (PlGF) und soluble fms-like tyrosine kinase-1 (sFlt-1) im Rahmen des Erst-Trimester-Screenings.
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia
First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia
Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis
Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction – implications as a preeclampsia treatment
Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria
Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
Die Wertigkeit von placental growth factor (PlGF) und soluble fms-like tyrosine kinase-1 (sFlt-1) im Rahmen des Erst-Trimester-Screenings.
A dynamic prediction model for preeclampsia using the sFlt-1/PLGF ratio combined with multiple factors
Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia
sFlt-1 als diagnostischer Biomarker bei pulmonaler Hypertonie
Dinucleotide repeat polymorphism in Fms-like tyrosine kinase-1 (Flt-1) gene is not associated with preeclampsia
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia